The flavivirus protease as a target for drug discovery.

作者: Matthew Brecher , Jing Zhang , Hongmin Li

DOI: 10.1007/S12250-013-3390-X

关键词: Viral replicationVirologyProteaseNS3Drug discoveryGenomeDrug developmentBiologyFlavivirusAntiviral drug

摘要: Many flaviviruses are significant human pathogens causing considerable disease burdens, including encephalitis and hemorrhagic fever, in the regions which they endemic. A paucity of treatments for flaviviral infections has driven interest drug development targeting proteins essential to flavivirus replication, such as viral protease. During genome is translated a single polyprotein precursor, must be cleaved into individual by complex protease, NS3, its cofactor, NS2B. Because this cleavage an obligate step life-cycle, protease attractive target antiviral development. In review, we will survey recent studies NS3 active site, well NS2B/NS3 interaction site determined from crystal structures.

参考文章(123)
David L Wyles, Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection. Topics in antiviral medicine. ,vol. 20, pp. 139- ,(2012)
P Warrener, J K Tamura, M S Collett, RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. Journal of Virology. ,vol. 67, pp. 989- 996 ,(1993) , 10.1128/JVI.67.2.989-996.1993
DEBORAH S. ASNIS, RICK CONETTA, GLENN WALDMAN, ALEX A. TEIXEIRA, The West Nile Virus Encephalitis Outbreak in the United States (1999-2000) Annals of the New York Academy of Sciences. ,vol. 951, pp. 161- 171 ,(2006) , 10.1111/J.1749-6632.2001.TB02694.X
Brett D. Lindenbach, Charles M. Rice, Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function Journal of Virology. ,vol. 73, pp. 4611- 4621 ,(1999) , 10.1128/JVI.73.6.4611-4621.1999
Dahai Luo, Ting Xu, Cornelia Hunke, Gerhard Grüber, Subhash G. Vasudevan, Julien Lescar, Crystal structure of the NS3 protease-helicase from dengue virus Journal of Virology. ,vol. 82, pp. 173- 183 ,(2008) , 10.1128/JVI.01788-07